Skip to content
FrontierPicks

Covered

AGYS · Agilysys

Conviction · Medium · more likely to lead the S&P 500 over the next three months, by a modest margin

Wrong if: a daily close below $99

Note written ·

Price against the kill line

23.2% clear of its kill line on the 13 November 2026 close.

How to read this

The red mark is the price level of the published kill line: a close through it (a weekly close, on a weekly line) would prove the research note wrong on price. The dot is where the stock closed on 13 November 2026; a dot left of the mark has closed through its line.

The scale is stretched near the line, so close calls are easy to see. More than 8% from the line, the stock reads well clear, with a hollow dot to show the figure is off the drawn scale.

The kill line is the research note's own test. The portfolio sells on business facts, not on a price. How the portfolio decides

AGYSAgilysys
$99.00
$121.94
23.2%well clear

Three months against the kill line

AGYS daily closes from 17 August 2026 to 13 November 2026, last $121.94, against its kill line: a daily close below $99.00. 17 August 2026: $111.3318 August 2026: $111.9619 August 2026: $116.7120 August 2026: $113.3821 August 2026: $113.8024 August 2026: $113.8225 August 2026: $114.5026 August 2026: $114.6127 August 2026: $120.5028 August 2026: $117.8831 August 2026: $116.411 September 2026: $112.492 September 2026: $113.513 September 2026: $114.154 September 2026: $111.368 September 2026: $108.039 September 2026: $106.1010 September 2026: $105.4711 September 2026: $104.4914 September 2026: $109.0715 September 2026: $104.6416 September 2026: $105.4617 September 2026: $102.2118 September 2026: $100.1321 September 2026: $100.2522 September 2026: $100.3723 September 2026: $101.1824 September 2026: $99.6825 September 2026: $99.6428 September 2026: $97.1029 September 2026: $96.3430 September 2026: $97.081 October 2026: $100.312 October 2026: $99.265 October 2026: $99.506 October 2026: $98.797 October 2026: $101.928 October 2026: $102.599 October 2026: $105.0312 October 2026: $105.7113 October 2026: $109.2614 October 2026: $107.4115 October 2026: $113.4216 October 2026: $109.9019 October 2026: $112.2320 October 2026: $116.4021 October 2026: $116.0222 October 2026: $120.0723 October 2026: $120.6926 October 2026: $123.4527 October 2026: $115.8128 October 2026: $115.1329 October 2026: $115.8630 October 2026: $115.802 November 2026: $117.983 November 2026: $119.874 November 2026: $122.645 November 2026: $119.766 November 2026: $121.099 November 2026: $123.9310 November 2026: $124.1511 November 2026: $123.4512 November 2026: $121.5913 November 2026: $121.94

Daily closes, to . Red: the kill line, a daily close below $99.00, on record since 10 November 2026. The shares are up 9.5% since the close; the S&P 500 is down 2.1% over the same sessions. Figures in the note can cover a different window.

Kill line

A daily close below $99, under the 50-day moving average, which would erase the post-report recovery. A cut to the at-least-34% FY2027 subscription-growth guidance would also show the case failing.

Research onlyNot in the portfolio.

The portfolio's record →

Key figures from the filings · Technology

Quarter to 30 September 2026, filed 26 October 2026; valuation at the 13 November 2026 close

Revenue, latest quarter ($M)
93.4
Revenue, change on a year (%)
+17.7
Gross margin (%)
64.6
Operating margin (%)
16.3
Free cash flow, four quarters ($M)
80.3
Price to earnings (×)
77.6
Free-cash-flow yield (%)
2.3
All filed numbers

What Agilysys reports to the SEC in its quarterly and annual filings. Each group states its period and filing date once; a figure dated otherwise says so. Built from the filings known on .

Results by quarter Each quarter with the day its figures were first filed, and the day of a later filing that changed them
Quarter to Revenue ($M) On a year (%) Gross margin (%) Operating margin (%)
first filed 93.4 +17.7 64.6 16.3
first filed 87.7 +14.3 63.5 11.1
first filed 82.9 +11.7 64.4 15.2
first filed 80.4 +15.6 62.5 14.6
first filed 79.3 +16.1 61.7 17.8
first filed 76.7 +20.7 61.7 5.9
Income Quarter to 30 September 2026, filed 26 October 2026
Pre-tax income ($M) 16.7
Net income ($M) four quarters: 44.4 13.2
Diluted shares, change on a year (%) against the quarter to 30 September 2025 +0.6
Cash flow Four quarters to 30 September 2026, filed 26 October 2026
Operating cash flow ($M) 82.1
Capital spending ($M) 1.9
Free cash flow ($M) 80.3
Balance sheet At 30 September 2026, filed 26 October 2026
Cash and short-term investments ($M) 138
Debt ($M) Not available
Net cash, cash less debt ($M) Not available
Deferred revenue ($M) +10.7% on a year 69.6
Backlog, orders not yet delivered ($M) 164
Receivables ($M) 41.1
Inventory ($M) 10.4
Shareholders' equity ($M) 358
Valuation At the 13 November 2026 close, filed figures to 26 October 2026
Market value ($M) 3,441
Enterprise value, market value plus net debt ($M) Not available
Enterprise value to sales (×) Not available
Enterprise value to operating income (×) Not available
Price to earnings (×) 77.6
Price to book value (×) 9.6
Free-cash-flow yield (%) 2.3

Short interest (FINRA, settled 15 October 2026, published 26 October 2026): 6.2% of shares outstanding sold short, 6.7 days of average trading to cover, +5.4% since the previous report.

Insiders' open-market trades SEC Form 4, by trade date, to
Window Bought Sold
90 daysfrom $0 $2.3M
12 monthsfrom $78K $24.6M

The thesis

Agilysys's shares are modestly more likely than not to beat the S&P 500 because its hotel and casino software is moving customers to subscriptions faster than management guided. The company raised its fiscal year 2027 (FY2027) guidance on 26 October 2026, and the fiscal third-quarter (Q3) report, expected in late January 2027, shows whether the at-least-34% full-year subscription growth outlook holds.

Fiscal second-quarter (Q2) subscription revenue grew 32.6% to $44.2 million, above the "approach 30%" the chief financial officer gave on 27 July 2026 (Agilysys release, 26 October 2026). Total revenue was a record $93.4 million, up 17.7%. The Form 10-Q for the quarter puts product revenue at $11.99 million and cash at $137.6 million on 30 September 2026.

The rating is Medium because the raised guidance carries checkable quarterly numbers and the January report is the next test of them. The only company filings since the report are insider Form 4s: option exercises with tax withholding on 30 October 2026, and two small open-market sales (SEC Form 4 filings). The shares closed at $123.45 on 11 November 2026, up 7.2% over three months. That price sits below every post-report analyst target cited here, so the market has priced in the raised outlook only in part.

Bullish and bearish views on Agilysys, Inc.

The bull case on Agilysys, Inc. (AGYS), in brief: subscription growth beat the stated target. The bear case: the outlook leans on the second half.

Bull case

  • Subscription growth beat the stated target. Subscription revenue reached 71.2% of recurring revenue, up from 65.5% a year earlier (Agilysys release, 26 October 2026). It grew 10% from the prior quarter, per the Q2 call.
  • The remaining quarters carry numbers. Chief financial officer Dave Wood guided to quarterly subscription revenue increases of about $3.5 million to $3.7 million for the rest of FY2027 (Q2 call, 26 October 2026). That gives fiscal Q3 a checkable figure.
  • Sales point to more growth. Management called Q2 its best second quarter for sales, with sales up 33% in domestic hotels, resorts and cruise, 42% in domestic food service management and 47% in Asia-Pacific (Q2 call, 26 October 2026).
  • Marriott has further to run. More than 2,000 Marriott properties are live and select-service implementations are virtually complete. Management said the full-service rollout has not reached the halfway point by properties, rooms or revenue (Q2 call, 26 October 2026).
  • Product revenue has recovered. Q2 product revenue of $11.99 million was the highest in nearly three years, and product backlog ended the quarter 90% higher than a year earlier (Form 10-Q; Q2 call, 26 October 2026). Management guides to $20 million to $22 million of product revenue for the second half.
  • Analysts lifted targets after the report. Oppenheimer raised its target to $135 on 27 October 2026 and Piper Sandler to $140 on 28 October 2026. MarketBeat's consensus target was $141.25 on 5 November 2026, up from $124.60 on 4 October 2026.

Bear case

  • The outlook leans on the second half. Fiscal Q2 delivered 32.6% against a full-year guide of at least 34%, so the remaining two quarters must carry the acceleration (Q2 call, 26 October 2026).
  • Fiscal Q3 margin is guided down. Management expects adjusted earnings before interest, taxes, depreciation and amortisation (EBITDA) margin slightly above 22% in fiscal Q3. That leaves the 25% full-year margin guide dependent on fiscal Q4 (Q2 call, 26 October 2026).
  • Contract liabilities declined. The Form 10-Q shows contract liabilities, largely amounts billed ahead of revenue, at $69.6 million on 30 September 2026, down from $83.0 million on 31 March 2026.
  • Product revenue is lumpy by nature. One-time hardware and licence sales have driven revenue misses at past reports. The $20 million to $22 million second-half product guide sets a bar the January report can fail (Q2 call, 26 October 2026).
  • Insiders sold after the report. Director John Mutch sold 750 shares at an average of $114.96 on 29 October 2026, and chief financial officer William David Wood III sold 961 shares at $116.00 on 2 November 2026 under a Rule 10b5-1 pre-arranged trading plan (SEC Form 4 filings). Chief commercial officer Joe Abdelrahman sold 1,002 shares at $114.64 on 1 September 2026 (SEC Form 4). The sales are small against 28,215,805 shares outstanding, but no insider purchase appears in the filings.

Price setup

The shares closed at $123.45 on 11 November 2026, after $122.64 on 4 November 2026, $119.76 on 5 November 2026, $121.09 on 6 November 2026 and $124.15 on 10 November 2026. The 3-month change is 7.2%, measured from a $115.20 close on 13 August 2026.

On adjusted daily closes as of 11 November 2026, the 50-day moving average is $109.47 and the 200-day moving average is $92.37. The price sits above both, and the 50-day sits above the 200-day. The 52-week closing low was $62.19 on 10 April 2026, so the shares have roughly doubled from that April trough.

The 52-week high is $133.32, set intraday on 12 November 2025, and the last close is 7.4% below it. Recovering that level would put the shares at a one-year high. The closes from 4 November to 11 November 2026 moved without a new business fact, so the case still rests on the January report.

The share count is small, at 28,215,805 on 16 October 2026 per the Form 10-Q, so single-holder sales and index flows move the price more than the market value suggests. No earnings date falls inside the next 30 days.

Catalysts ahead

  • ~26 January 2027 (est.): Fiscal Q3 FY2027 report; the date is not yet announced, and the prior-year fiscal Q3 report came on 26 January 2026. Tests the $3.5M–$3.7M quarterly subscription increase, the slightly-above-22% margin guide, the $20M–$22M second-half product guide and the at-least-34% full-year subscription outlook.

What would change the view

A daily close below $99, under the 50-day moving average, which would erase the post-report recovery. A cut to the at-least-34% FY2027 subscription-growth guidance would also show the case failing.

The risks this note tracks, each with what would confirm it:

  • Subscription increases fall short of the $3.5M–$3.7M quarterly pace needed for the at-least-34% full-year outlook. Confirmed by: a fiscal Q3 subscription revenue increase below $3.5M, or a cut to the 34% guidance at the next report.
  • Lumpy one-time product revenue misses, as it has at past reports. Confirmed by: total revenue below consensus with product revenue as the cause, or second-half product revenue tracking under the $20M–$22M guide.
  • Margin dips more than guided in fiscal Q3 and the fiscal Q4 recovery slips, putting the 25% full-year margin guide at risk. Confirmed by: fiscal Q3 adjusted EBITDA margin below the slightly-above-22% guidance, or a lower fiscal Q4 margin target.
  • The Marriott full-service rollout runs unevenly; management cautioned on the 26 October 2026 call that a project this size will not run smoothly at every stage. Confirmed by: management commentary at the next report that full-service property go-lives have slowed or moved later.
  • Insider selling broadens beyond small, pre-planned sales and compensation-related withholding. Confirmed by: new Form 4 filings showing CEO open-market sales, or CFO or director sales outside a Rule 10b5-1 plan, at prices above $114.

What it trades with

Agilysys trades as a small-cap application software company, so it tends to move with growth-software multiples and small-cap risk appetite. Its business depends on hotel, resort, cruise, casino and food-service technology spending, which ties demand to the hospitality cycle. The Marriott rollout is a single-customer concentration that links part of the subscription trajectory to one operator's implementation schedule.

The evidence, claim by claim (8)
  1. Subscription revenue was $44.2M, up 32.6% and up 10% sequentially, reaching 71.2% of recurring revenue from 65.5% a year earlier. Agilysys Q2 FY2027 earnings release and call · as of
  2. FY2027 guidance was raised to $374M–$378M revenue from $368M–$373M, to at least 34% subscription growth from at least 32%, and to a 25% adjusted EBITDA margin from 24%. Agilysys Q2 FY2027 earnings release and call · as of
  3. The CFO guided quarterly subscription revenue increases of about $3.5M–$3.7M for the rest of FY2027 and a fiscal Q3 adjusted EBITDA margin slightly above 22%. Agilysys Q2 FY2027 earnings call · as of
  4. Q2 product revenue was $11.99M, the highest in nearly three years; product backlog was 90% higher than a year earlier, and second-half product revenue is guided at $20M–$22M. Agilysys Form 10-Q and Q2 FY2027 earnings call · as of
  5. More than 2,000 Marriott properties are live; management said the full-service rollout has not reached the halfway point by properties, rooms or revenue. Agilysys Q2 FY2027 earnings call · as of
  6. Cash was $137.6M on 30 September 2026, up from $116.9M on 31 March 2026; contract liabilities were $69.6M, down from $83.0M. Agilysys Form 10-Q for the quarter ended 30 September 2026 · as of
  7. Oppenheimer raised its target to $135 on 27 October 2026 and Piper Sandler to $140 on 28 October 2026; MarketBeat's consensus target was $141.25, with targets from $135 to $145. Company news headlines; MarketBeat forecast page · as of
  8. CFO William David Wood III sold 961 shares at $116.00 on 2 November 2026 under a Rule 10b5-1 plan; director John Mutch sold 750 shares at an average $114.96 on 29 October 2026. SEC Form 4 filings dated 30 October 2026 and 3 November 2026 · as of

Sources

Every buy and sale, with its reason, is published in the portfolio feed. Follow the portfolio feed → Follow @frontierpicks on X